Correlation of Bridging Therapy (BT) and Lymphodepleting Chemotherapy (LDC) with clinical outcomes in patients (pts) with relapsed/refractory Diffuse Large B-cell Lymphoma (r/r DLBCL) treated with tisagenlecleucel Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Andreadis, C
  • Tam, CS
  • Borchmann, P
  • Jaeger, U
  • McGuirk, JP
  • Holte, H
  • Waller, EK
  • Jaglowski, S
  • Bishop, MR
  • Foley, Ronan
  • Westin, JR
  • Fleury, I
  • Ho, PJ
  • Mielke, S
  • Teshima, T
  • Salles, GA
  • Schuster, SJ
  • Bachanova, V
  • Maziarz, RT
  • Besien, K
  • Izutsu, K
  • Wagner-Johnston, ND
  • Kato, K
  • Corradini, P
  • Tiwari, R
  • Awasthi, R
  • Lawniczek, T
  • Eldjerou, LK
  • Kersten, MJ

publication date

  • October 1, 2020